HCWB - HCW Biologics Inc
Previous close
0.461
0 0%
Share volume: 5,507
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.46
0.00
0.00%
Fundamental analysis
9%
Profitability
0%
Dept financing
11%
Liquidity
47%
Performance
7%
Performance
5 Days
-1.91%
1 Month
-25.66%
3 Months
-57.71%
6 Months
-67.99%
1 Year
-75.74%
2 Year
-81.99%
Key data
Stock price
$0.46
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.40 - $2.18
52 WEEK CHANGE
-$0.74
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
Company detail
CEO:
Region: US
Website:
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
by leveraging our immunology expertise, hcw is developing proprietary immunotherapy candidates to address chronic inflammation through inflammasome modulation and senescent cell clearance.
Recent news